PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer
Status:
Completed
Trial end date:
2022-11-16
Target enrollment:
Participant gender:
Summary
This exploratory clinical study aims to assess the safety and preliminary efficacy of an
immunotherapy using PD-1 knockout anti-MUC1 CAR-T cells in the treatment of advanced
MUC1-positive breast cancer
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University